Article Versions Notes

Esen M, Fischer-Herr J, Gabor JJ, Gaile JM, Fleischmann WA, Smeenk GW, de Moraes RA, Bélard S, Calle CL, Woldearegai TG, et al. First-in-Human Phase I Trial to Assess the Safety and Immunogenicity of an Orf Virus-Based COVID-19 Vaccine Booster. Vaccines. 2024; 12(11):1288. https://doi.org/10.3390/vaccines12111288

Esen, Meral, Johanna Fischer-Herr, Julian Justin Gabor, Johanna Marika Gaile, Wim Alexander Fleischmann, Geerten Willem Smeenk, Roberta Allgayer de Moraes, Sabine Bélard, Carlos Lamsfus Calle, Tamirat Gebru Woldearegai, and et al. 2024. "First-in-Human Phase I Trial to Assess the Safety and Immunogenicity of an Orf Virus-Based COVID-19 Vaccine Booster" Vaccines 12, no. 11: 1288. https://doi.org/10.3390/vaccines12111288

Esen, M., Fischer-Herr, J., Gabor, J. J., Gaile, J. M., Fleischmann, W. A., Smeenk, G. W., de Moraes, R. A., Bélard, S., Calle, C. L., Woldearegai, T. G., Egger-Adam, D., Haug, V., Metz, C., Reguzova, A., Löffler, M. W., Balode, B., Matthies, L. C., Ramharter, M., Amann, R., & Kremsner, P. G. (2024). First-in-Human Phase I Trial to Assess the Safety and Immunogenicity of an Orf Virus-Based COVID-19 Vaccine Booster. Vaccines, 12(11), 1288. https://doi.org/10.3390/vaccines12111288